I'm glad I don't have to rely on this fellow's research - quite...

First 11 Last

Share
Profile

Follow
hammerjx

146 Posts.

16

01/06/17

08:32

Post #: 25030746
Share

Originally posted by usc75 ↑

Thanks, patprice...

Especially is one considers the following:

On 27th April 2017, BKL released its Third Quarter Results Announcement.

Key Facts: Consider 1st 9 months of FY17 (compared with same period FY16):

* Sales down 6.7%

* EBITDA down 39.4%

* EBIT down 42.2%

* Profit Before Tax down 44.5% ...and that's just for starters...

PS: But according to the word-picture painted by Management and Board, BKL is rosy red!

PPS: It's just a pity that it's fast becoming a highly unprofitable business. Makes one wonder why?

Flash Forward to Today: not one of the above Critical Issues was addressed.

This must leave shareholders wondering what's going on while founder Marcus Blackmore remains absent?

Instead, shareholders were treated to waffle, waffle and more herbal waffle.

PS: Sales without profits (now) and dividends (?tomorrow) leaves Share Price teetering on the abyss.

PPS: It's far safer with feet on the ground looking up to, rather than wavering arms and toes facing down from, the abyss.

Expand

I'm glad I don't have to rely on this fellow's research - quite likely to be an analyst for one of the funds. He certainly likes to rationalise. He omits to mention that those figures from April 2017 relate to the pcp (nine months to March 31 2016) which was NPAT record growth up 145% from the pcp (nine months to March 31 2015). Your credibility is shot. Just be honest.

BKL Price at posting: $102.02 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

ME1

Banshee's historic trenches prove rich in antimony and gold for GDM

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

HotCopper Highlights: Your most watched stocks for Week 46, 2024

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

There are more pages in this discussion • 49 more messages in this thread...

First 11 Last

Add BKL (ASX) to my watchlist

I'm glad I don't have to rely on this fellow's research - quite...

Top Stories

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Cyclone signs MOU with Vale for development of Iron Bear play

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

HotCopper Highlights: Your most watched stocks for Week 46, 2024

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Featured News